Minerva Neurosciences | 销售成本

股票价格
6.31
每天变化
0.66 11.68%
每月一次
46.06%
每年
225.26%
Q1 预测
2.46




销售成本 更改 日
Acadia Pharmaceuticals USD 21.65M 913K 2025-09
Adma Biologics USD 58.64M 3.88M 2025-09
ALKERMES USD 51.59M 2.13M 2025-09
AstraZeneca USD 2.8B 328M 2025-09
BioCryst Pharmaceuticals USD 12.27M 9.04M 2024-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Cipla INR 29.1B 1.16B 2025-12
Clal Biotechnology ILS 16.49M 2.64M 2022-06
Compugen USD 1.65M 10K 2025-09
CSL USD 1.79B 2.15B 2025-06
Dynavax Technologies USD 14.4M 368K 2025-09
Eli Lilly USD 3.37B 363.7M 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
GlaxoSmithKline GBP 2.61B 377M 2025-12
Grifols EUR 1.32B 22.75M 2025-09
Halozyme Therapeutics USD 73M 8.88M 2025-09
Ionis Pharmaceuticals USD 2.34M 1.81M 2025-09
J&J USD 7.97B 689M 2025-12
Merck USD 3.32B 531M 2025-12
Minerva Neurosciences 386K 31K 2024-06
Neurocrine Biosciences USD 264M 252.7M 2025-09
Novartis USD 3.54B 217M 2025-09
Novavax USD 60.62M 91.77M 2024-09
Pfizer USD 6.29B 2.12B 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 4.29B 421M 2025-12
Takeda JPY 401.15B 184.07B 2025-12
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12


Minerva Neurosciences 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.